Latest Interviews
Showing 1786–1800 of 6,409 interview transcripts.
Clear all filtersWindsurf: The Making of a Billion-Dollar AI Company | Leigh Marie Braswell, Kleiner Perkins
Leigh Marie Braswell, Molly O'Shea
Kleiner Perkins deployed its $2 billion combined KP21 fund through a nine-partner team led by Lee Marie Braswell, utilizing a "major and minor" specialization model to target early and growth stages in AI-driven sectors like Windsurf and Glean. The firm is actively validating high-velocity startups such as Windsurf, which recently hit $100 million ARR by pivoting from GPU infrastructure to a unified IDE, while rejecting the notion that current market conditions prevent the creation of historically significant companies. By enforcing rigorous diligence on recurring revenue and leveraging a "talent vortex" hiring strategy, the partnership aims to capture outliers in coding agents and enterprise automation despite macroeconomic turbulence and skepticism regarding AI profit margins.
- Goldman Sachs13 min
Stagflation and the Fed's next move
The U.S. economy confronts a stagflationary shock driven by spending cuts, restrictive immigration policies, and tariff uncertainty, creating a complex backdrop for Federal Reserve monetary strategy. Policymakers are advised to pause rate decisions at the May meeting to assess new trade data while maintaining a tough rhetorical stance to anchor inflation expectations without pre-committing to specific future cuts. As the Fed balances its dual mandate amidst potential political pressure, global investors are cautiously retaining dollar allocations despite signs of institutional skepticism and capital outflows that are currently characterized as temporary positioning rather than a permanent strategic shift.
- The Economist7 min
Why US tariffs on China will hurt American shoppers
Effective May 2, the Trump administration revoked the "de minimis" exemption, eliminating duty-free status for Chinese imports under $800 and directly impacting the US market-dependent business models of fast-fashion giants Shein and Temu. Facing high tariff costs that threaten their core pricing advantages, these companies currently rely on direct shipping from Chinese hubs while navigating geopolitical pressure from Beijing against relocating manufacturing to avoid tariffs. Experts anticipate Shein and Temu will survive this regulatory shift by diversifying into new global markets and transitioning into multinational corporations despite strict US efforts to close trade loopholes.
- 80,000 Hours3h 15m
How Westminster Works — and Why It Doesn't | Ian Dunt
This analysis identifies systemic structural flaws in the UK's Westminster governance, arguing that political failures stem from concentrated executive power, a First Past the Post electoral system, and a culture prioritizing party loyalty over professional expertise. Specific dysfunctions include high civil service turnover, arbitrary legislative deadlines, and catastrophic decision-making evident during the 2021 Afghanistan evacuation, where a lack of specialist knowledge and rigid incentives hindered effective response. To counter these issues, the summary proposes comprehensive reforms such as proportional representation, tenure incentives to retain specialist knowledge, and restoring parliamentary control over the legislative timetable to ensure balanced, long-term policy stability.
- a16z37 min
What Is an AI Agent?
Guido Appenzeller, Matt Bornstein, Yoko Li
Industry experts define AI agents as multi-step systems capable of dynamic reasoning and tool usage, distinguishing them from simple prompt wrappers despite widespread marketing inflation. Current market adoption is constrained by data silos, security gaps in authentication, and the technical difficulty of enabling non-deterministic models to interact reliably with fragmented user environments. Ultimately, the field is shifting toward specialized workflows and multimodal capabilities, with agents expected to become invisible infrastructure within two to five years rather than standalone products.
- Y Combinator53 min
Windsurf CEO: Betting On AI Agents, Pivoting In 48 Hours, And The Future of Coding
Varun Mohan, Mark Mandelmann, Jr., Melanie Warrick, Amanda Schade, Mark Blyth
Windsurf, led by founders who pivoted from GPU virtualization to AI coding tools in 2022, has rapidly scaled to over one million developers and achieved eight-figure annual revenue without a dedicated sales team. The company differentiates itself through an "agentic editor" that handles codebases exceeding 100 million lines by combining AST parsing with real-time GPU re-ranking, enabling automated legacy migration and multi-step code execution. This rapid growth was driven by a strategy of immediate product iteration, such as transforming a VS Code extension into a standalone IDE to overcome architectural limitations, all while maintaining a hiring philosophy centered on engineers capable of executing high-stakes pivots.
- Goldman Sachs10 min
Time to buy bonds?
Despite a macroeconomic shift toward higher inflation and lower growth driven by tariff announcements since April, the 10-year Treasury yield has remained stable while credit spreads have partially recovered from their initial widening. Goldman Sachs Asset Management has strategically increased portfolio duration and favored Investment Grade credit over High Yield, citing bond outperformance versus equities and the U.S. dollar's status as a global safe haven. Although the firm acknowledges an increased recession probability and sector divergence within travel, it concludes that current market pricing does not yet fully reflect downside risks, prompting continued allocation to structured credit opportunities.
What Does it Take to Be Good at Series A and B Today?
Rory O'Driscoll, Jason Lemkin, Fabrice Grinda, Harry Stebbings
Venture capital markets are currently navigating a dual reality defined by an AI-fueled "gold rush" and a constrained liquidity environment where exit windows remain closed. Investors are diverging between aggressive "megatrend" bets on artificial intelligence and defense technology versus deep-value plays in digitized B2B sectors, while grappling with rapidly evolving risks such as model obsolescence and geopolitical instability. This high-velocity landscape is forcing strategic shifts toward earlier exits, a preference for "deranged" founders capable of exponential scaling, and a structural reevaluation of how private company lifecycles align with technological obsolescence.
- Goldman Sachs37 min
Nasdaq CEO Adena Friedman on the future of public markets
Adena Friedman, John Waldron, Allison
Led by CEO Adena Friedman, the NASDAQ has evolved from a US electronic stock exchange into a global technology platform supplying critical infrastructure to 130 markets while prioritizing liquidity, transparency, and anti-financial crime solutions. The organization recently navigated record trading volumes and leverages hybrid cloud architecture and generative AI to enhance market resilience, with a specific strategic focus on the anti-financial crime sector following the Verifin acquisition. Looking forward, leadership advocates for structural regulatory reforms to reverse the decline in public listings and attract capital back to public markets against the backdrop of rapid private market growth.
- The Diary Of A CEO1h 28m
Michelle Obama: This Is A Scam! People Were Running From Us Because We Were Black!
Michelle Obama, Steven, Craig Robinson, Barack Obama
Michelle and Craig Robinson's podcast explores their upbringing in Chicago, where their parents instilled resilience and advocacy through personal sacrifice and community leadership. The conversation details Michelle's pivotal career shift from corporate law to public service, influenced by personal tragedy and her relationship with Barack Obama, alongside the challenges of navigating the White House as the first Black First Lady. Concluding with their mother's recent passing, the siblings emphasize a legacy of mentorship, urging audiences to prioritize character, practice boundary-setting, and navigate adversity with empathy.
- a16z27 min
Biotech CEO on where we are in the fight to cure cancer
Former Halozyme CEO Jonathan Lim leverages his experience scaling biotech startups to lead Araska Therapeutics, a company targeting the historically undruggable RAS pathway with a pipeline including the pan-RAF inhibitor Naporafenib. Concurrently, his family office, City Hill Ventures, manages a diversified portfolio of life sciences assets and media projects that parallel the high-risk, high-reward dynamics of pharmaceutical development. Lim's strategy emphasizes capital preservation and the combination of novel molecular glues with standard therapies to drive long-term remission rates beyond current limits in pancreatic, lung, and colon cancers.
- Dwarkesh Patel1h 16m
Mark Zuckerberg — AI will write most Meta code in 18 months
Meta has officially launched four Llama 4 models, immediately releasing the efficient Scout and Maverick variants while developing a massive two-trillion parameter "Behemoth" to distill intelligence into smaller, consumer-ready agents. The company is shifting its evaluation metrics from external leaderboards to internal product performance, prioritizing low-latency, full-duplex voice interactions and AI-driven content that reacts dynamically to user input across its billion-person ecosystem. By leveraging internal coding agents to accelerate development and advocating for a dual ad-supported and premium business model, Meta aims to narrow the gap with closed-source competitors while navigating infrastructure bottlenecks that will constrain the pace of an anticipated intelligence explosion.
- a16z1h 31m
How Andreessen Horowitz Disrupted VC & What’s Coming Next
Marc Andreessen, Ben Horowitz, Erik Torenberg
Established in 2009 by Ben Horowitz and Marc Andreessen, Andreessen Horowitz (a16z) redefined venture capital by replacing the passive "Sushi Boat" model with an active, capital-intensive platform strategy designed to provide deep operational support for "Full Stack" companies across verticals like AI and crypto. This structural shift responded to an overfunded market and dysfunctional public exits, enabling the firm to scale from a traditional two-person partnership into a decentralized network of expert operators that rivals major tech giants in domain capability. By prioritizing founder success over secrecy and leveraging a media-centric branding approach, a16z has transformed the VC asset class into a mechanism that fuels a wider pool of ambitious entrepreneurs despite the enduring unpredictability of human judgment in project selection.
- Goldman Sachs14 min
How AI and geopolitics are reshaping cybersecurity
Driven by escalating cyber threats and the strategic necessity for platform consolidation, the cybersecurity sector has witnessed record-breaking M&A activity despite a soft overall market, highlighted by Google's $32 billion acquisition of Wiz. While macroeconomic volatility creates near-term uncertainty for IPOs, the industry's resilient, "sticky" spending habits and significant private equity capital are redirecting focus toward cloud security and AI-driven defense solutions. This evolving landscape, bolstered by government partnerships and geopolitical tensions, positions the field as a critical competitive advantage even as it grapples with emerging risks from generative AI and autonomous attack vectors.
- Sequoia Capital56 min
The Quest to ‘Solve All Diseases’ with AI: Isomorphic Labs’ Max Jaderberg
Founded to construct a general AI-driven drug design engine, Isomorphic Labs has leveraged Demis Hassabis's Nobel Prize-winning leadership and Max Yoderberg's AI expertise to release AlphaFold 3, a diffusion-based model that predicts the 3D structures of proteins, DNA, RNA, and small molecules. By replacing months of traditional crystallization with instant in-silico analysis, the company collaborates with industry partners like Eli Lilly and Novartis to navigate the 10^60-sized chemical space and advance programs in oncology and immunology without operating its own wet labs. This approach positions AI as a fundamental, indispensable tool for the entire pharmaceutical industry within five years, while the firm advocates for new regulatory frameworks to validate these predictive models for clinical trials.